SomaLogic Q1 Revenues Fall 11 Percent but Beat Wall Street Consensus
Six weeks after a management shakeup, the proteomics firm is looking for unspecified "inorganic" opportunities to become profitable.
SomaLogic Enters Chinese Market With Biostar Technology Partnership
Shanghai-based life sciences technology supplier Biostar Technology will be the first to offer SomaLogic’s 7,000-plex SomaScan assay in China.
SomaLogic CEO Steps Down Amid Board Turnover; Firm's Q4 Revenues Drop 18 Percent
Ex-CEO Roy Smythe is one of three people stepping down from the board. He will be replaced by Adam Taich, formerly executive VP of life sciences at SomaLogic.
SomaLogic Seeks 'Strategic Alternatives' for Dx Business to Focus on Life Science Market
The proteomics firm is in talks to either spin off its SomaSignal assays unit or to partner with another company to boost its diagnostics efforts.
In Brief This Week: SomaLogic, Centogene, Yourgene, Epigenomics, Biodesix, More
News items for the week of Dec. 19, 2022.
May 13, 2022
May 12, 2022
SomaLogic Q1 Revenues Grow 22 Percent
Mar 30, 2022
Jan 6, 2022
Jun 30, 2021